Medtronic plc (MDT) Stock

About Medtronic plc

Medtronic plc is led by CEO Geoffrey Straub Martha, employs 95,000 people, headquartered in Galway, US, publicly traded since 1973.

Medtronic plc (MDT) stock trades at $88.48 with a market capitalization of $113.26B. The stock is valued at a price-to-earnings (P/E) ratio of 21.67, price-to-book of 2.26, price-to-sales of 3.02. Over the past 52 weeks the stock has ranged between $73.31 and $106.33, and currently trades 16.8% below its 52-week high. It pays a dividend yielding 3.25%.

On profitability, Medtronic plc generates a return on equity (ROE) of 10.60%, return on capital employed of 8.33%, an operating margin of 17.76%, a net profit margin of 13.93%.

In its most recent fiscal year, Medtronic plc reported annual revenue of $36.4B, net profit of $4.8B, revenue has compounded at 3.8% a year over the last five years, profit at 5.9% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.56, a current ratio of 1.85, total assets of $91.7B, $2.2B in cash and equivalents.

MDT has a beta of 0.57 (less volatile than the overall market).